AwardedSpainGoodsDynamic purchasing system€414,382
Adjudicación del Contrato Específico del Medicamento USTEKINUMAB, derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, para la CORPORACIÓ DE SALUT DEL MARESME I LA SELVA
- Published
- Published 10 July 2026
Overview
The Corporació de Salut del Maresme i la Selva has awarded a contract for the supply of the pharmaceutical medicine Ustekinumab, valued at 414,382.32 EUR, to Janssen-Cilag SA and Sandoz Farmacéutica SA. The procurement was conducted through the dynamic acquisition system for exclusive medicines managed by the Consorci de Salut i d'Atenció Social de Catalunya.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €414,382
- Procedure
- Selective
- Contract type
- Dynamic purchasing system
- Published
- 10 July 2026
Various medicinal products
Award outcome
- Awarded value
- €414,382
- Award date
- 29 June 2026
- Contract period
- 29 June 2026 → 24 June 2027
- JANSSEN-CILAG, SA
- SANDOZ FARMACEUTICA, SA
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
10 July 2026
Contracting authority
Corporació de Salut del Maresme i la Selva
Procuring entityCalella, Spain
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.